News and Events
Use tab to navigate through the menu items.
GrowthCap Top 25 Healthcare Investors - William Dai
William Dai named one of GrowthCap's Top 25 Healthcare Investors of 2022
Apexigen to go public via SPAC merger
Huma.AI Series A & Product Update
2022 SVB Report Results
Robert Kamen joins ShangBay Capital as our newest Senior Advisor
Contraline closes $10.7M Series A Financing Round
Tvardi Therapeutics among Fierce Biotech's "Fierce 15" of 2021
Devoro Medical Reaches Acquisition Agreement with Boston Scientific!
Laplace Interventional Announces $7.9 Million Series A for its Transcatheter Tricuspid Valve